888-899-6266        info@BioCoreUSA.com   
0 item(s) $0.00 
 
TISSUE ARRAYS
 
B-80Ova-3bOvary cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV803a
Cores80Cases80
Row number8Column number10
Core Diameter(mm)1.5Thickness(µm)5.0
Tissue Array TypeFFPESpeciesHuman
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Product name:B-80Ova-3b
 
Ovary cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV803a
 
Price: $255.00
 
PLEASE SELECT TYPE
 
Qty:
 
To Check Overlapping Cases
 
 
Legend:
Ova
-Ovary
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (III)
 
Malignant (IIIC)
 
Malignant (IV)
TISSUE  ARRAYS B-80Ova-3b
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageType
A1134FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignant
A2242FOvarySerous adenocarcinoma2T1N0M0IMalignant
A3359FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
A4448FOvarySerous papillary adenocarcinoma with necrosis1T1N0M0IMalignant
A5538FOvarySerous papillary adenocarcinoma1T3cN1M1IVMalignant
A6647FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
A7725FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
A8851FOvarySerous papillary adenocarcinoma with degeneration1T3cN1M0IIICMalignant
A9957FOvarySerous adenocarcinoma1T1cN0M0ICMalignant
A101053FOvarySerous adenocarcinoma2T1aN0M0IAMalignant
B11161FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignant
B21260FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignant
B31332FOvarySerous papillary adenocarcinoma1T1N0M0IMalignant
B41453FOvarySerous adenocarcinoma1T1N0M0IMalignant
B51533FOvarySerous adenocarcinoma1T1N0M0IMalignant
B61650FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignant
B71722FOvarySerous papillary adenocarcinoma1T2bN0M0IIBMalignant
B81864FOvarySerous adenocarcinoma with necrosis2T3N1M1IVMalignant
B91926FOvarySerous papillary adenocarcinoma1T3cN1M0IIICMalignant
B102056FOvarySerous adenocarcinoma1T2N0M0IIMalignant
C12148FOvarySerous adenocarcinoma2T1bN0M0IBMalignant
C22235FOvarySerous adenocarcinoma2T1aN0M0IAMalignant
C32352FOvarySerous adenocarcinoma2T1aN0M0IAMalignant
C42459FOvarySerous adenocarcinoma2T1cN0M0ICMalignant
C52568FOvarySerous adenocarcinoma2T1aN0M0IAMalignant
C62646FOvarySerous adenocarcinoma2T1aN0M0IAMalignant
C72749FOvarySerous adenocarcinoma2T3cN0M0IIICMalignant
C82853FOvarySerous papillary adenocarcinoma1T2N0M1IVMalignant
C92952FOvarySerous adenocarcinoma2T2N0M0IIMalignant
C103051FOvarySerous adenocarcinoma2T1cN0M0ICMalignant
D13154FOvarySerous adenocarcinoma2T2bN0M0IIBMalignant
D23256FOvarySerous adenocarcinoma2T3cN1M1IVMalignant
D33354FOvarySerous adenocarcinoma with necrosis2T3cN1M0IIICMalignant
D43451FOvarySerous adenocarcinoma2T1aN0M0IAMalignant
D53560FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignant
D63651FOvarySerous adenocarcinoma1T3N1M0IIICMalignant
D73773FOvarySerous adenocarcinoma2T2aN0M0IIAMalignant
D83838FOvarySerous adenocarcinoma3T3bN1M0IIICMalignant
D93947FOvarySerous adenocarcinoma2T1aN0M0IAMalignant
D104058FOvarySerous adenocarcinoma with necrosis3T1N0M0IMalignant
E14141FOvarySerous adenocarcinoma3T1N0M0IMalignant
E24250FOvarySerous adenocarcinoma3T1N0M0IMalignant
E34349FOvarySerous papillary adenocarcinoma3T2N0M0IIMalignant
E44452FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
E54546FOvarySerous adenocarcinoma3T3aN1M0IIICMalignant
E64646FOvarySerous adenocarcinoma3T2cN1M0IIICMalignant
E74757FOvarySerous adenocarcinoma3T3cN1M0IIICMalignant
E84852FOvarySerous adenocarcinoma with necrosis3T2N0M0IIMalignant
E94975FOvarySerous adenocarcinoma3T2N0M0IIMalignant
E105054FOvarySerous adenocarcinoma with degeneration3T1bN0M0IBMalignant
F15166FOvarySerous adenocarcinoma with necrosis3T3N1M0IIICMalignant
F25249FOvarySerous adenocarcinoma3T3N1M0IIICMalignant
F35354FOvarySerous adenocarcinoma with necrosis3T3cN1M0IIICMalignant
F45442FOvarySerous adenocarcinoma3T3cN1M0IIICMalignant
F55560FOvarySerous adenocarcinoma3T1aN0M0IAMalignant
F65647FOvarySerous adenocarcinoma3T2aN0M0IIAMalignant
F75756FOvarySerous adenocarcinoma3T3N1M0IIICMalignant
F85847FOvarySerous adenocarcinoma3T1cN0M0ICMalignant
F95972FOvarySerous adenocarcinoma-T1aN0M0IAMalignant
F106055FOvarySerous adenocarcinoma (sparse)3T2N0M0IIMalignant
G16149FOvarySerous adenocarcinoma3T2N0M0IIMalignant
G26232FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant
G36360FOvarySerous adenocarcinoma3T1bN0M0IBMalignant
G46445FOvaryMucinous cystadenocarcinoma1T1aN0M0IAMalignant
G56534FOvaryMucinous adenocarcinoma1T1N0M0IMalignant
G66640FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant
G76734FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignant
G86848FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant
G96965FOvaryMucinous adenocarcinoma2T2aN0M0IIAMalignant
G107048FOvaryMucinous adenocarcinoma2T1bN0M0IBMalignant
H17139FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant
H27251FOvaryMucinous adenocarcinoma with degeneration2T1bN0M0IBMalignant
H37354FOvaryMucinous adenocarcinoma2T2aN0M0IIAMalignant
H47449FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant
H57541FOvaryMucinous adenocarcinoma3T1bN0M0IBMalignant
H67629FOvaryMucinous adenocarcinoma3T3N0M0IIIMalignant
H77749FOvaryEndometrioid adenocarcinoma (sparse)2T1N0M0IMalignant
H87855FOvaryEndometrioid adenocarcinoma2T1N0M0IMalignant
H97955FOvaryEndometrioid adenocarcinoma with degeneration2T1N0M0IMalignant
H108050FOvaryClear cell carcinoma*T1N0M0IMalignant
I181
 
 
BioCoreUSA Corporation
6024 Ridge Ave, Suite 116-236
Philadelphia PA 19128
United States
 
CONTACT US
Email:
Customerservices@biocoreusa.com
Info@biocoreusa.com
TEL: 888-899 6266
SUPPORT
Delivery
Privacy Policy
Terms & Conditions
FAQs